Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- TMO
- Price
- 438.15
- Stock movement up
- +10.71 (2.51%)
- Company name
- Thermo Fisher Scientific Inc
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 167.59B
- Ent value
- 214.21B
- Price/Sales
- 3.96
- Price/Book
- 3.41
- Div yield
- 0.39%
- Div growth
- 15.54%
- Growth years
- 6
- FCF payout
- 7.33%
- Trailing P/E
- 27.31
- Forward P/E
- 18.65
- PEG
- 2.28
- EPS growth
- 16.38%
- 1 year return
- -23.63%
- 3 year return
- -9.31%
- 5 year return
- 8.12%
- 10 year return
- 12.66%
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
Dividend yield - 5y
Loading...
Dividend yield data
| Dividend per share | 1.72 |
| Dividend yield | 0.39% |
| Payout frequency | Quarterly |
| Maximum yield | 0.41% |
| Average yield | 0.24% |
| Minimum yield | 0.16% |
| Discount to avg yield | 39.14% |
| Upside potential | 64.32% |
| Yield as % of max yield | 95.71% |
Yield distribution (inverse percentile) - 5y
Loading...
Yield distribution data
| Dividend yield | 0.39% |
| Current yield distribution | 0.32% |
| Yield at 100% (Min) | 0.16% |
| Yield at 90% | 0.19% |
| Yield at 80% | 0.20% |
| Yield at 50% (Median) | 0.23% |
| Yield at 20% | 0.27% |
| Yield at 10% | 0.29% |
| Yield at 0% (Max) | 0.41% |
Dividend per share
Loading...
Dividend per share data
| Years of growth | 6 years |
| CCC status | Dividend Challenger |
| Dividend per share | 1.72 |
| Payout frequency | Quarterly |
| Ex-div date | 14 Mar 2025 |
| EPS (TTM) | 15.98 |
| EPS (1y forward) | 23.50 |
| EPS growth (5y) | 16.38% |
| EPS growth (5y forward) | 12.00% |
Dividend growth
Loading...
Please create a free account or log in to access this chart
Dividend growth data
| TMO | S&P500 | |
| DGR MR | 10.26% | -13.74% |
| DGR TTM | 11.11% | 6.60% |
| DGR 3 years | 16.74% | 5.24% |
| DGR 5 years | 15.54% | 5.40% |
| DGR 10 years | 8.84% | 7.07% |
| DGR 15 years | - | 6.12% |
| Time since last change announced | 55 days |
| EPS growth (5y) | 16.38% |
| EPS growth (5y forward) | 12.00% |
Payout ratio
Loading...
Please create a free account or log in to access this chart
Payout ratio data
| EPS coverage | FCF coverage | |
| TTM | 9.29% | 7.33% |
| Average | - | - |
| Forward | 7.32% | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 27.31 |
| Price to OCF | 18.42 |
| Price to FCF | 21.56 |
| Price to EBITDA | 16.28 |
| EV to EBITDA | 20.81 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.96 |
| Price to Book | 3.41 |
| EV to Sales | 5.06 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 382.50M |
| EPS (TTM) | 15.98 |
| FCF per share (TTM) | 20.25 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 42.37B |
| Gross profit (TTM) | 17.39B |
| Operating income (TTM) | 7.17B |
| Net income (TTM) | 6.14B |
| EPS (TTM) | 15.98 |
| EPS (1y forward) | 23.50 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 41.03% |
| Operating margin (TTM) | 16.92% |
| Profit margin (TTM) | 14.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.64B |
| Net receivables | 9.80B |
| Total current assets | 23.78B |
| Goodwill | 46.73B |
| Intangible assets | 16.26B |
| Property, plant and equipment | 0.00 |
| Total assets | 100.36B |
| Accounts payable | 2.61B |
| Short/Current long term debt | 35.31B |
| Total current liabilities | 14.60B |
| Total liabilities | 51.27B |
| Shareholder's equity | 49.10B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 9.10B |
| Capital expenditures (TTM) | 1.32B |
| Free cash flow (TTM) | 7.78B |
| Dividends paid (TTM) | 570.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 12.50% |
| Return on Assets | 6.11% |
| Return on Invested Capital | 7.27% |
| Cash Return on Invested Capital | 9.21% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 429.99 |
| Daily high | 440.73 |
| Daily low | 420.00 |
| Daily Volume | 2.66M |
| All-time high | 667.24 |
| 1y analyst estimate | 653.51 |
| Beta | 0.79 |
| EPS (TTM) | 15.98 |
| Dividend per share | 1.72 |
| Ex-div date | 14 Mar 2025 |
| Next earnings date | 22 Apr 2025 |
Downside potential
Loading...
Downside potential data
| TMO | S&P500 | |
| Current price drop from All-time high | -34.33% | -12.89% |
| Highest price drop | -71.16% | -56.47% |
| Date of highest drop | 15 Apr 1999 | 9 Mar 2009 |
| Avg drop from high | -17.29% | -11.07% |
| Avg time to new high | 18 days | 12 days |
| Max time to new high | 2091 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
167.59B
Marketcap category
Large-cap
Description
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
Employees
122000
Website
Investor relations
SEC filings
CEO
Marc Casper
Country
USA
City
Waltham
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page